2018

Filter by Year:

Shares in Australian pharma Immuron are going nuts

8 March 2018

Shares in pharmaceutical company Immuron Limited surged by 80% when it announced promising results in testing its anti-inflammation drug. The Australian microbiome is developing and commercialising treatments for inflammatory and infectious diseases.